Human germline heterozygous gain-of-function STAT6 variants cause severe allergic disease
Journal of Experimental Medicine · 01.05.2023 · 220 (5)
DOI: 10.1084/jem.20221755 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Experimental Medicine, online erschienen am 08.03.2023. Verfasst von Mehul Sharma und 59 weiteren Autor:innen. Beteiligte Einrichtung: Dept. of Pediatrics, BC Children's Hospital, University of British Columbia , Vancouver, Canada. Hauptthemen laut MEDLINE: Asthma, Food Hypersensitivity. Die Arbeit wurde bisher 117-mal zitiert (Crossref) und nennt 105 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, Howard Hughes Medical Institute, Canadian Institutes of Health Research.
Abstract (Originalsprache)
STAT6 (signal transducer and activator of transcription 6) is a transcription factor that plays a central role in the pathophysiology of allergic inflammation. We have identified 16 patients from 10 families spanning three continents with a profound phenotype of early-life onset allergic immune dysregulation, widespread treatment-resistant atopic dermatitis, hypereosinophilia with esosinophilic gastrointestinal disease, asthma, elevated serum IgE, IgE-mediated food allergies, and anaphylaxis. The cases were either sporadic (seven kindreds) or followed an autosomal dominant inheritance pattern (three kindreds). All patients carried monoallelic rare variants in STAT6 and functional studies established their gain-of-function (GOF) phenotype with sustained STAT6 phosphorylation, increased STAT6 target gene expression, and TH2 skewing. Precision treatment with the anti–IL-4Rα antibody, dupilumab, was highly effective improving both clinical manifestations and immunological biomarkers. This study identifies heterozygous GOF variants in STAT6 as a novel autosomal dominant allergic disorder. We anticipate that our discovery of multiple kindreds with germline STAT6 GOF variants will facilitate the recognition of more affected individuals and the full definition of this new primary atopic disorder.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Dept. of Pediatrics, BC Children's Hospital, University of British Columbia , Vancouver, Canada.
- Dept. of Paediatrics and Adolescent Medicine, School of Clinical Medicine, The University of Hong Kong , Hong Kong, China.
- Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM, Necker Hospital for Sick Children, Paris, France.
- Imagine Institute, University of Paris-Cité, Paris, France.
- Dept. of System Medicine, Pediatric Chair, University of Tor Vergata, Rome, Italy.
- Academic Dept. of Pediatrics (DPUO), Unit of Clinical Immunology and Vaccinology, IRCCS Bambin Gesù Children Hospital, Rome, Italy.
ORCID-Profile: Mehul Sharma, Daniel Leung, Mana Momenilandi, Lauren C W Jones, Lucia Pacillo, Alyssa E James, Jill R Murrell, Selket Delafontaine, Jesmeen Maimaris, Maryam Vaseghi-Shanjani, Kate L Del Bel, Henry Y Lu, Gilbert T Chua, Silvia Di Cesare, Oriol Fornes, Zhongyi Liu, Gigliola Di Matteo, Maggie P Fu, Donato Amodio, Issan Yee San Tam, Gavin Shueng Wai Chan, Ashish A Sharma, Joshua Dalmann, Robin van der Lee, Géraldine Blanchard-Rohner, Susan Lin, Quentin Philippot, Phillip A Richmond, Jessica J Lee, Allison Matthews, Michael Seear, Alexandra K Turvey, Rachael L Philips, Terri F Brown-Whitehorn, Christopher J Gray, Kosuke Izumi, James R Treat, Kathleen H Wood, Justin Lack, Asya Khleborodova, Julie E Niemela, Xingtian Yang, Rui Liang, Lin Kui, Christina Sze Man Wong, Grace Wing Kit Poon, Alexander Hoischen, Caspar I van der Made, Jing Yang, Koon Wing Chan, Jaime Sou Da Rosa Duque, Pamela Pui Wah Lee, Marco Hok Kung Ho, Brian Hon Yin Chung, Huong Thi Minh Le, Wanling Yang, Pejman Rohani, Ali Fouladvand, Hassan Rokni-Zadeh, Majid Changi-Ashtiani
Förderung
- NIAID NIH HHS
- Howard Hughes Medical Institute
- Canadian Institutes of Health Research
- Genome British Columbia
- BC Children’s Hospital Foundation
- Canada Research Chair
- CIHR Frederick Banting
- University of British Columbia
Zitieren
APA
Sharma, M., Leung, D., Momenilandi, M., Jones, L. C. W., Pacillo, L., James, A. E., Murrell, J. R., Delafontaine, S., Maimaris, J., Vaseghi-Shanjani, M., Del Bel, K. L., Lu, H. Y., Chua, G. T., Di Cesare, S., Fornes, O., Liu, Z., Di Matteo, G., Fu, M. P., Amodio, D., …, & Changi-Ashtiani, M. (2023). Human germline heterozygous gain-of-function STAT6 variants cause severe allergic disease. Journal of Experimental Medicine, 220(5). https://doi.org/10.1084/jem.20221755
Vancouver
Sharma M, Leung D, Momenilandi M, Jones LCW, Pacillo L, James AE, et al. Human germline heterozygous gain-of-function STAT6 variants cause severe allergic disease. Journal of Experimental Medicine. 2023;220(5). doi:10.1084/jem.20221755
BibTeX
@article{Sharma2023,
author = {Sharma, Mehul and Leung, Daniel and Momenilandi, Mana and Jones, Lauren C W and Pacillo, Lucia and James, Alyssa E and Murrell, Jill R and Delafontaine, Selket and Maimaris, Jesmeen and Vaseghi-Shanjani, Maryam and Del Bel, Kate L and Lu, Henry Y and Chua, Gilbert T and Di Cesare, Silvia and Fornes, Oriol and Liu, Zhongyi and Di Matteo, Gigliola and Fu, Maggie P and Amodio, Donato and Tam, Issan Yee San and Chan, Gavin Shueng Wai and Sharma, Ashish A and Dalmann, Joshua and van der Lee, Robin and Blanchard-Rohner, Géraldine and Lin, Susan and Philippot, Quentin and Richmond, Phillip A and Lee, Jessica J and Matthews, Allison and Seear, Michael and Turvey, Alexandra K and Philips, Rachael L and Brown-Whitehorn, Terri F and Gray, Christopher J and Izumi, Kosuke and Treat, James R and Wood, Kathleen H and Lack, Justin and Khleborodova, Asya and Niemela, Julie E and Yang, Xingtian and Liang, Rui and Kui, Lin and Wong, Christina Sze Man and Poon, Grace Wing Kit and Hoischen, Alexander and van der Made, Caspar I and Yang, Jing and Chan, Koon Wing and Rosa Duque, Jaime Sou Da and Lee, Pamela Pui Wah and Ho, Marco Hok Kung and Chung, Brian Hon Yin and Le, Huong Thi Minh and Yang, Wanling and Rohani, Pejman and Fouladvand, Ali and Rokni-Zadeh, Hassan and Changi-Ashtiani, Majid},
title = {Human germline heterozygous gain-of-function STAT6 variants cause severe allergic disease},
journal = {Journal of Experimental Medicine},
year = {2023},
volume = {220},
number = {5},
doi = {10.1084/jem.20221755}
}
EUVIMED